Vicineum
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vicineum, covering 2023-10-26 to 2023-10-26. Get the full timeline:
Most recent: Clinical Trial Update: Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG) [Phase 1]